p16INK4a Rabbit Polyclonal Antibody
Usd: 315 Special Discount
Specification
Catalog# ER1803-53
p16INK4a Rabbit Polyclonal Antibody
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ER1803-53_Europe.pdf
- No MSDS Found
Overview
Product Name
p16INK4a Rabbit Polyclonal Antibody
Antibody Type
Rabbit Polyclonal Antibody
Immunogen
Synthetic peptide within C-terminal human CDKN2A/p16INK4a.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IHC-P, FC
Target Molecular Weight
Predicted band size: 16 kDa
Positive Control
HeLa cell lysate, HEK-293 cell lysate, Saos-2 cell lysate, HeLa, human colon cancer tissue, human stomach cancer tissue.
Conjugation
unconjugated
RRID
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Immunogen affinity purified.
Application Dilution
-
WB
-
1:1,000
-
IF-Cell
-
1:50-1:200
-
IHC-P
-
1:50-1:200
-
FC
-
1:50-1:100
Target
Function
p16 (also known as p16INK4a, cyclin-dependent kinase inhibitor 2A, CDKN2A, multiple tumor suppressor 1 and numerous other synonyms), is a protein that slows cell division by slowing the progression of the cell cycle from the G1 phase to the S phase, thereby acting as a tumor suppressor. It is encoded by the CDKN2A gene. A deletion (the omission of a part of the DNA sequence during replication) in this gene can result in insufficient or non-functional p16, accelerating the cell cycle and resulting in many types of cancer. p16 can be used as a biomarker to improve the histological diagnostic accuracy of grade 3 cervical intraepithelial neoplasia (CIN). p16 is also implicated in the prevention of melanoma, oropharyngeal squamous cell carcinoma, cervical cancer, vulvar cancer and esophageal cancer. p16 was discovered in 1993. It is a protein with 148 amino acids and a molecular weight of 16 kDa that comprises four ankyrin repeats. The name of p16 is derived from its molecular weight, and the alternative name p16INK4a refers to its role in inhibiting cyclin-dependent kinase CDK4.
Background References
1. Okamoto A et al. Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA 91:11045-11049 (1994).
2. Bockstaele L et al. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK \'inhibitors\'. Mol Cell Biol 26:5070-5085 (2006).
Sequence Similarity
Belongs to the CDKN2 cyclin-dependent kinase inhibitor family.
Tissue Specificity
Widely expressed but not detected in brain or skeletal muscle. Isoform 3 is pancreas-specific.
Post-translational Modification
Phosphorylation seems to increase interaction with CDK4.
Subcellular Location
Nucleus. Cytoplasm.
UNIPROT
Synonyms
CCM2 antibody
CDK4 inhibitor p16 INK4 antibody
CDK4I antibody
CDKN2 antibody
CDKN2A antibody
Cell cycle negative regulator beta antibody
CMM2 antibody
Cyclin dependent kinase 4 inhibitor A antibody
Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) antibody
Cyclin Dependent Kinase Inhibitor 2A antibody
ExpandCCM2 antibody
CDK4 inhibitor p16 INK4 antibody
CDK4I antibody
CDKN2 antibody
CDKN2A antibody
Cell cycle negative regulator beta antibody
CMM2 antibody
Cyclin dependent kinase 4 inhibitor A antibody
Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) antibody
Cyclin Dependent Kinase Inhibitor 2A antibody
Cyclin dependent kinase inhibitor 2A isoform 4 antibody
Cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody
Cyclin dependent kinase inhibitor p16 antibody
INK4 antibody
INK4A antibody
MLM antibody
MTS1 antibody
Multiple tumor suppressor 1 antibody
p14 antibody
p16 antibody
P16INK4 antibody
p16INK4a antibody
p19 antibody
p19Arf antibody
TP16 antibody
CollapseImages
-
Western blot analysis of p16INK4a on different lysates with Rabbit anti-p16INK4a antibody (ER1803-53) at 1/1,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HEK-293 cell lysate
Lane 3: Saos-2 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 16 kDa
Observed band size: 16 kDa
Exposure time: 1 minute; ECL: K1801;
15% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ER1803-53) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of p16INK4a on different lysates with Rabbit anti-p16INK4a antibody (ER1803-53) at 1/1,000 dilution.
Lane 1: HeLa-si NT cell lysate
Lane 2: HeLa-si p16INK4a cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 16 kDa
Observed band size: 16 kDa
Exposure time: 9 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ER1803-53) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/100,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling p16INK4a with Rabbit anti-p16INK4a antibody (ER1803-53) at 1/200 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p16INK4a antibody (ER1803-53) at 1/200 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue using anti-CDKN2A/p16INK4a antibody. Counter stained with hematoxylin. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes.
-
Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue using anti-CDKN2A/p16INK4a antibody. Counter stained with hematoxylin. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes.
-
Flow cytometric analysis of HeLa cells labeling p16INK4a.
Cells were fixed and permeabilized. Then stained with the primary antibody (ER1803-53, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Theaflavin-3,3′-digallate attenuates chondrocyte senescence via modulating FGF7 and KEAP1/NRF2 signaling pathway
Journal: Free Radical Biology And Medicine
DOI: 10.1016/j.freeradbiomed.2026.05.303
IF: 8
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 May
-
Screening for ferroptosis genes related to endometrial carcinoma and predicting of targeted drugs based on bioinformatics
Journal: Archives Of Toxicology
DOI:
IF: 6.1
Application: IHC-P
Reactivity: Human
Publish date: 2024 May
Alternative Products
p16INK4a Mouse Monoclonal Antibody [A4A5]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Mouse Monoclonal Antibody [PD01-16]
Application: IHC-P,WB,IF-Cell,IF-Tissue
Reactivity: Human
Conjugate: unconjugated
p16INK4a Mouse Monoclonal Antibody [A4A3]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Rabbit Monoclonal Antibody [PD01-16]
Application: WB,IHC-P,IF-Cell
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Rabbit Monoclonal Antibody [SU0702]
Application: WB,IP
Reactivity: Human
Conjugate: unconjugated
Products with the same target and pathway
p16INK4a Recombinant Rabbit Monoclonal Antibody [SU0702] - BSA and Azide free
Application: WB,IP
Reactivity: Human
Conjugate: unconjugated
p16INK4a Mouse Monoclonal Antibody [A4A5]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Mouse Monoclonal Antibody [PD01-16]
Application: IHC-P,WB,IF-Cell,IF-Tissue
Reactivity: Human
Conjugate: unconjugated
p16INK4a Mouse Monoclonal Antibody [A4A3]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Rabbit Monoclonal Antibody [PD01-16]
Application: WB,IHC-P,IF-Cell
Reactivity: Human
Conjugate: unconjugated
p16INK4a Recombinant Rabbit Monoclonal Antibody [SU0702]
Application: WB,IP
Reactivity: Human
Conjugate: unconjugated
p16INK4a Rabbit Polyclonal Antibody
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated